Yasuko Orba

Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant

Rigel Suzuki, Daichi Yamasoba, Izumi Kimura et al. · Nature · 2022 · 749 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +9

Gold Nanoparticles as a Vaccine Platform: Influence of Size and Shape on Immunological Responses <i>in Vitro</i> and <i>in Vivo</i>

Kenichi Niikura, Tatsuya Matsunaga, Tadaki Suzuki et al. · ACS Nano · 2013 · 626 citations

Life Sciences, Immunology, Infectious Diseases +17

Discovery of S-217622, a Noncovalent Oral SARS-CoV-2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19

Yuto Unoh, Shota Uehara, Kenji Nakahara et al. · Journal of Medicinal Chemistry · 2022 · 590 citations · Full text

Medicine, Infectious Diseases, Pharmacology +15

Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike

Daichi Yamasoba, Izumi Kimura, Hesham Nasser et al. · Cell · 2022 · 348 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15

The sphingosine-1-phosphate transporter Spns2 expressed on endothelial cells regulates lymphocyte trafficking in mice

Shigetomo Fukuhara, Szandor Simmons, Shunsuke Kawamura et al. · Journal of Clinical Investigation · 2012 · 317 citations · Full text

Life Sciences, Cell Biology, Immunology +17